hero-line-left hero-line-top

Press releases

hero-line-bottom
hero-line-horizontal
temp-hero-icon

AMITA Health and Syapse Partner to Advance Precision Medicine Capabilities for Cancer Patients

CHICAGO, Ill., and SAN FRANCISCO, Calif., September 9, 2020 — AMITA Health, one of the largest health systems in Illinois, and Syapse®…

Read

Syapse Appoints David Pomerantz as Chief Commercial Officer

SAN FRANCISCO, Calif., September 3, 2020 — Syapse®, a real-world evidence company accelerating the delivery of precision medicine thro…

Read

Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Evidence Related to COVID-19 and Cancer

SAN FRANCISCO, Calif., August 11, 2020 — Syapse®, a real-world data company accelerating the delivery of precision medicine through th…

Read

Syapse Deepens Scientific and Technical Expertise with Key Additions to Leadership Team

SAN FRANCISCO, Calif., August 6, 2020 — Syapse®, a real-world evidence company accelerating the delivery of precision medicine through…

Read

Syapse Highlights Real-World Evidence Related to COVID-19 and Cancer at AACR Virtual Meeting

SAN FRANCISCO, Calif., July 22, 2020 — Syapse®, a real-world data company accelerating the delivery of precision medicine through the…

Read

Syapse Expands Real-World Data Network in Asia Through Ajou University Hospital Partnership

SAN FRANCISCO, Calif. and SEOUL, SOUTH KOREA, July 14, 2020 - Syapse®, a real-world data company accelerating the delivery of precisi…

Read

Syapse Announces Research Using Real-World Evidence at ASCO20 Virtual

SAN FRANCISCO – May 29, 2020 – Syapse today announced multiple research abstracts based on real-world data at the ASCO20 Virtual Annual Meet…

Read

Syapse Announces $30M Financing to Advance the Use of Real-World Evidence

SAN FRANCISCO – May 28, 2020 – Syapse, today announced $30 million in new equity funding to accelerate the creation and use of real-world ev…

Read

Syapse, FDA, and Advocate Aurora Health to Present Pneumonitis Safety Data in Plenary Talk at AACR Virtual Meeting

AACR Virtual Annual Meeting Plenary Session April 27, 2020 at 4:00 PM EDT - - - SAN FRANCISCO – April 27, 2020 – Syapse announced that r…

Read

Syapse Appoints Dr. Thomas D. Brown as Chief Medical Officer

SAN FRANCISCO – October 16, 2019 – Syapse today announced the appointment of Thomas D. Brown, MD, MBA as its first Chief Medical Officer. Dr…

Read

Syapse Appoints Fletcher Payne as Chief Financial Officer

SAN FRANCISCO – September 10, 2019 – Syapse, a company accelerating precision medicine through insights derived from its global health syste…

Read

Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evidence

SAN FRANCISCO – August 14, 2019 – Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signe…

Read

Seoul National University Hospital and Syapse Sign Multi-Year Renewal Agreement to Expand Access to Precision Medicine in South Korea

SAN FRANCISCO and SEOUL, SOUTH KOREA - August 6, 2019 - Syapse, a company accelerating precision medicine through insights derived from its…

Read

Syapse Announces Collaboration with Pfizer in Oncology Precision Medicine Focused on Outcomes Research Using Real-World Evidence

SAN FRANCISCO – July 23, 2019 – Syapse, a company accelerating precision medicine through insights derived from its global health syste…

Read

Amgen and Syapse Enter Precision Medicine Collaboration in Oncology

THOUSANDS OAKS, Calif - May 2, 2019 - Amgen (NASDAQ:AMGN), a world leader in biotechnology, and Syapse, a company powering precision medicin…

Read

Syapse Oncology Platform Achieves HITRUST CSF Certification

SAN FRANCISCO - April 10, 2019 - Syapse, the leader in powering precision medicine through a global health system network, today announ…

Read

Syapse Presents Data Demonstrating the Effectiveness of its Real-World Data Platform in Harmonizing Molecular Testing Results Across Commercial and Hospital-based Laboratories at Scale

SAN FRANCISCO - April 1, 2019 - Syapse, the leader in powering precision medicine through a global health system network, today announc…

Read

Syapse Hosts Inaugural Precision Medicine Council to Drive Progress in Precision Oncology

San Francisco, Calif. (October 18, 2018) – Syapse, the leading precision medicine company, is convening innovative health systems today in S…

Read

Software Veteran James Lim Joins Syapse as Senior Vice President of Product Development

San Francisco, Calif. (July 26, 2018) – Syapse announced today that James Lim has joined the company as Senior Vice President of Product Dev…

Read

Syapse Launches Precision Medicine Council to Advance Health System Adoption of Precision Oncology

San Francisco, Calif. (June 7, 2018) — Syapse, the leading precision medicine company, announced today the formation of the Syapse Precisio…

Read

Evolent Health CEO Frank Williams Joins Syapse Board of Directors

San Francisco, Calif. (March 1, 2018) – Syapse, a leading precision medicine company, announced today that Frank Williams, the co-founder an…

Read

Syapse Expands Philadelphia-area Office

San Francisco, Calif. (February 13, 2018) – Syapse, a leader in precision medicine solutions, has expanded its Philadelphia-area location in…

Read

Medidata and Syapse Announce Partnership to Bring Oncology Clinical Trials into Precision Medicine Era

New York and San Francisco, Calif. (January 31, 2018) – Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and d…

Read

Syapse Expands Precision Medicine to Asia through Partnerships with Seoul National University Hospital and Megazone

San Francisco, Calif. and Seoul, Republic of Korea (January 30, 2018) – Syapse, a leading precision medicine company, announced today it is…

Read

Syapse Raises $30 Million to Expand Access to Precision Oncology

San Francisco, Calif. (November 14, 2017) – Syapse, a leader in precision medicine solutions, has raised $30 million in Series D financing,…

Read

Aurora Cancer Care Teams With Syapse to Launch Precision Medicine Program to Bring Greater Cancer Treatment Options to Patients

Milwaukee, Wis. – Aurora Cancer Care and Syapse, a market leader in precision oncology solutions, have teamed to launch…

Read

Precision Medicine Leader Syapse Announces Ken Tarkoff as New CEO

Palo Alto, Calif. (March 15, 2017) – Syapse, a market leader in precision oncology solutions, announced today that Ken Tarkoff is joining th…

Read

Dignity Health and Catholic Health Initiatives Team Up to Launch the Largest Community-Based Precision Medicine Program in the U.S.

SAN FRANCISCO, Calif. and ENGLEWOOD, Colo., September 19, 2016 – Dignity Health and Catholic Health Initiatives (CHI), t…

Read

Henry Ford Health System and Syapse Partner to Launch Cancer Precision Medicine Program

WASHINGTON, D.C., June 29, 2016 - Henry Ford Health System, one of the nation’s leading comprehensive and integrated health system…

Read

Catholic Health Initiatives and Syapse Launch National Cancer Precision Medicine Program

WASHINGTON, D.C.; PALO ALTO, Calif.; ENGLEWOOD, Colo., June 29, 2016 - Catholic Health Initiatives (CHI), the nation’s second-largest nonpro…

Read

Oncology Precision Network (OPeN) Announces Data Sharing Commitments at Vice President Biden's Cancer Moonshot Summit

PALO ALTO, Calif.; SALT LAKE CITY, Utah; RENTON, Wash.; STANFORD, Calif., June 29, 2016 - An initiative to end cancer is getting a boost fro…

Read

TAPUR Study Achieves Milestones: Forty-Nine Patients Consent to Participate, Bayer and Merck Sign on as Drug Providers, and Thirty-Seven Sites Are Participating Twelve Weeks Post-Launch

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) announced today that Bayer and Merck are the most recent companies t…

Read

ASCO Kicks off Ground-Breaking Clinical Trial to Learn from Use of Approved Targeted Cancer Therapies Matched to Tumor Genomics

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today announced it has begun recruiting patients with advanced cancer for…

Read

White House Recognizes Intermountain Healthcare and Syapse for Their Commitment to Precision Medicine

SALT LAKE CITY, Utah and PALO ALTO, Calif., February 26, 2016 – On February 25th, leaders from Intermountain Healthcare, a not-for-profit he…

Read

Syapse Raises $25 Million Series C Round Led by Ascension Ventures to Expand Precision Medicine

PALO ALTO, Calif. and CLAYTON, Mo., January 12, 2016 – Syapse, the leader in precision medicine software, has completed the first close of a…

Read

Caris Life Sciences and Syapse Collaborate to Aggregate Oncology Data that Will Power Precision Medicine and Improve Patient Care

IRVING, Texas and PALO ALTO, Calif., November 18, 2015 – Caris Life Sciences®, a leading biotechnology company focused on fulfilling the pro…

Read

A Groundbreaking Global Alliance Forms to Find Effective Response to the Deadliest Human Brain Tumor

A message from Jonathan Hirsch, Syapse Founder & President: “Each year, tens of thousands of people around the world will receive a diagnos…

Read

Syapse Precision Medicine Platform Selected by Leading Oncology Society to Enable Targeted Agent and Profiling Utilization Registry (TAPUR) Study

PALO ALTO, Calif., June 1, 2015 – Syapse, the leading provider of precision medicine software, announced today that its Syapse Precision Med…

Read

ASCO Launches First-Ever Clinical Trial: Aims to Learn from Patients with Advanced Cancer Who Lack Standard Treatment Options

Five Leading Pharmaceutical Companies Will Support Innovative Study, Contribute Drugs CHICAGO, Ill., June 1, 2015 – The American Society of…

Read

New Studies by Intermountain Healthcare’s Intermountain Precision Genomics Reveal that Precision Medicine Improves Survival in Advanced Cancer Patients without Increasing Costs

SALT LAKE CITY, Utah, May 29, 2015 – Two new studies conducted by Intermountain Healthcare’s Intermountain Precision Gen…

Read